glp-1 side effect lawsuit in kentucky Wegovy | Lawyers for Wegovy Effects kentucky glp-1 gastric intestinal obstruction
Description
It is projected to reach USD 1,062.90 billion by 2035

Developing Microbiome-targeted Therapeutics Through Community-Based Metabolic Modelling

This content is not written by The New Pelican Brief Summary Curex is a telehealth platform offering compounded semaglutide and tirzepatide starting at $199/month with no membership fees

Key Takeaways GLP-1 therapy can lead to bloating due to its effects on gastric emptying and digestion

Immediate medical attention is required if taste changes are accompanied by: Severe, persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, decreased urination) Severe abdominal pain, particularly if persistent or worsening Symptoms of pancreatitis (severe upper abdominal pain radiating to the back, nausea, vomiting) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Symptoms of hypoglycemia (if also taking insulin or sulfonylureas): shakiness, sweating, confusion, irritability These symptoms may indicate serious adverse effects requiring urgent evaluation, including pancreatitis, gallbladder disease, gastroparesis, or severe dehydration

Yet, we suggest that physicians should pay more attention to patients with diabetes who take GLP1-RAs for glucose control
